Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06235502Not ApplicableRecruiting

Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project

Role: collaborator

NCT03847766Not ApplicableCompleted

Follow-up Using Patient-Reported Outcome (PRO) Measures in Patients With Chronic Kidney Disease

Role: collaborator

NCT05546073Not ApplicableCompleted

Advanced Point-of-care Technology During In-home Assessment Among Older Adults

Role: collaborator

NCT02337049Unknown

Preeclampsia Subtypes and Surrogate Markers of CVD Risk

Role: collaborator

NCT02136667Unknown

Preeclampsia and Circulating Biomarkers

Role: collaborator

NCT00252408Phase 4Completed

Danish Osteoporosis Prevention Study

Role: collaborator

All 6 trials loaded